Is This the Key to Bevacizumab Use in CRC?

Dr. David Kerr reports on a plausible study suggesting a link between MMR-deficient colon tumors and response to bevacizumab in the adjuvant setting.

Source: Medscape General Surgery Podcast - September 16, 2013 Category: Surgery Authors: Medscape Source Type: podcasts